CELSION CORPORATION

BIOLOGICAL

Catheters; medical treatment systems and devices used to treat and alleviate benign prostatic hyperplasia, namely, catheters;

CELSION

Medical apparatus for use in the delivery of microwave and/or rf energy for thermal therapy treatments, for thermally activated drug delivery and for thermally activated gene therapy for the treatment of disease;

CELSION

Medical services relating to the utilization of focused thermal therapy, microwave and/or RF energy for the treatment of disease, for thermally activated drug delivery, and for thermally activated gene therapy for the treatment of disease;

CELSION CORPORATION

Heat sensitive liposomes used as therapeutic drug delivery vehicles;Color is not claimed as a feature of the mark.;CORPORATION;

IMUNON

Pharmaceutical preparations, namely, immunotherapies and vaccines; biological preparations for the treatment of cancer and infectious disease pathogens; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity;Active chemical ingredients for use in the manufacture of pharmaceuticals; chemical, biological, and biochemical preparations for scientific purposes or general industrial manufacturing;Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; bioinformatics, chemical and biological analysis; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology;

IMUNON BIO

Pharmaceutical preparations; biological preparations; vaccines; pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for use in immunotherapy; therapeutic agents for promotion of cancer immunity;Active chemical ingredients for use in the manufacture of pharmaceuticals; Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes;Development of platform technology; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; bioinformatics, chemical and biological analysis; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, vaccination, and oncology;

LIPODOX

PHARMACEUTICAL PREPARATIONS OF THE TREATMENT OF CANCER; HEAT SENSITIVE LIPOSOMES ENCAPSULATED WITH PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER;LIPOSOMES;

PROLIEVE THERMODILATATION

PROSTATIC RELIEVE THERMODILATATION;Color is not claimed as a feature of the mark.;MEDICAL TREATMENT SERVICES, NAMELY, TREATMENT OF HYPERPLASIA AND BENIGN PROSTATIC HYPERPLASIA;

SRFA45

The mark consists of the letters SRFA in blue with a gold swirl design encompassing the number 45 in gold.;PHARMACEUTICAL PREPARATIONS OF THE TREATMENT OF CANCER; HEAT SENSITIVE LIPOSOMES ENCAPSULATED WITH PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER;S RFA 45;The color(s) blue and gold is/are claimed as a feature of the mark.;